RecruitingNCT05480644
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Sponsor
Duke University
Enrollment
300 participants
Start Date
Dec 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)
Exclusion Criteria1
- None
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05480644
Related Trials
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
NCT055598531 location
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
NCT057895891 location
Brain Imaging Biomarkers in Patients With Brain Metastasis
NCT041972971 location
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NCT0512423610 locations
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
NCT060473796 locations